Fem•Collect™ and Pure•SAL™-C: Unique Technologies for HPV Testing and Exosome Isolation

Why watch this on-demand webinar?

This webinar highlights innovative solutions for specimen collection, focusing on two transformative technologies. Fem•Collect™ enables simple and painless self-collection of cervico-vaginal samples for HPV testing, while Pure•SAL™-C streamlines the isolation of exosomes from saliva, delivering high-purity results for downstream diagnostic applications. Diagnostics, molecular biology, and laboratory science professionals will gain actionable insights to advance their work.

In this webinar, you will…

• The science behind Fem•Collect™: a non-invasive solution for HPV specimen collection
• The role of Pure•SAL™-C in exosome isolation for liquid biopsy diagnostics
• How porous polymer solutions enhance sample purity and testing efficiency 

Join us for an engaging exploration of two groundbreaking technologies revolutionizing specimen collection. The Fem•Collect™ and Pure•SAL™-C solutions combine Oasis Diagnostics® Corporation’s scientific expertise with Porex Filtration Group’s innovative engineering. From non-invasive self-collection of cervico-vaginal specimens for HPV testing to efficient isolation of highly purified exosomes, these technologies are shaping the future of diagnostics.

Porex is a global leader in porous polymer solutions with over 60 years of experience in the medical device industry. Known for its pioneering membrane technologies, Porex partners with more than 1,500 manufacturers worldwide. Join us and leverage Porex’s expertise to build safer, more reliable medical devices. 

Dr. Paul Slowey, Founder and Owner of Oasis Diagnostics® Corporation and its subsidiary Bamburgh Marrsh LLC, is a pioneer in oral fluid diagnostics with over 35 years of experience in clinical diagnostics and pharmaceuticals. Holding a Doctorate in Organic Chemistry from the University of Newcastle-upon-Tyne (UK), he has worked in academia, the pharmaceutical industry, and leadership roles in companies developing saliva diagnostics and oral fluid collection devices. Dr. Slowey has extensive expertise in strategic alliances and licensing, 45 peer-reviewed publications, 7 book chapters, 20 issued patents, and 10 patent applications, and has presented at key scientific symposia on topics including HIV diagnosis, cancer liquid biopsy testing, and nucleic acid diagnostics.